544 related articles for article (PubMed ID: 21649910)
1. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
3. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
4. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
5. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
7. The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.
Yam C; Merlo D; Stankovich J; Darby D; Gresle M; Kalincik T; Kilpatrick TJ; Lechner-Scott J; Taylor B; Barnett M; Butzkueven H; van der Walt A
Mult Scler Relat Disord; 2020 Aug; 43():102212. PubMed ID: 32474286
[TBL] [Abstract][Full Text] [Related]
8. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
9. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.
Trenova AG; Slavov GS; Draganova-Filipova MN; Mateva NG; Manova MG; Miteva LD; Stanilova SA
Neurol Res; 2018 Mar; 40(3):153-159. PubMed ID: 29297273
[TBL] [Abstract][Full Text] [Related]
11. The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed.
Berrigan LI; LeFevre JA; Rees LM; Berard JA; Francis A; Freedman MS; Walker LAS
Mult Scler Relat Disord; 2022 Dec; 68():104229. PubMed ID: 36279599
[TBL] [Abstract][Full Text] [Related]
12. Attention impairment associated with relapsing-remitting multiple sclerosis patients with mild incapacity.
Balsimelli S; Mendes MF; Bertolucci PH; Tilbery CP
Arq Neuropsiquiatr; 2007 Jun; 65(2A):262-7. PubMed ID: 17607425
[TBL] [Abstract][Full Text] [Related]
13. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
[TBL] [Abstract][Full Text] [Related]
14. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
15. New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
Wybrecht D; Reuter F; Pariollaud F; Zaaraoui W; Le Troter A; Rico A; Confort-Gouny S; Soulier E; Guye M; Maarouf A; Ranjeva JP; Pelletier J; Audoin B
PLoS One; 2017; 12(11):e0184650. PubMed ID: 29149177
[TBL] [Abstract][Full Text] [Related]
16. Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiency.
Wojtowicz M; Omisade A; Fisk JD
J Int Neuropsychol Soc; 2013 May; 19(5):551-8. PubMed ID: 23425598
[TBL] [Abstract][Full Text] [Related]
17. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
[TBL] [Abstract][Full Text] [Related]
18. PASAT in detecting cognitive impairment in relapsing-remitting MS.
Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
Appl Neuropsychol; 2007; 14(2):101-12. PubMed ID: 17523884
[TBL] [Abstract][Full Text] [Related]
19. Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
Lapshin H; Audet B; Feinstein A
Eur J Neurol; 2014 Feb; 21(2):281-6. PubMed ID: 24200243
[TBL] [Abstract][Full Text] [Related]
20. The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.
Wilken JA; Kane R; Sullivan CL; Wallin M; Usiskin JB; Quig ME; Simsarian J; Saunders C; Crayton H; Mandler R; Kerr D; Reeves D; Fuchs K; Manning C; Keller M
Mult Scler; 2003 Mar; 9(2):119-27. PubMed ID: 12708806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
